CVS Health’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025.

CVS Health (CVS) stock gains as company reports better than expected Q3 2024 ... CVS' Pharmacy & Consumer Wellness segment added $32.4B in revenue with ~12% YoY growth as prescriptions filled ...

Total revenues increased 4.2%, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, ... CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock.

Growth was broad-based across CVS’ three business segments, Health Care Benefits, Health Services and Pharmacy & Consumer ...

Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026 ...

Total revenue grew 10.3% to $88.92 billion, well above the FactSet consensus of $86.41 billion, as health care benefits revenue rose 17.6% and revenue for both the health services and pharmacy and ...

Shankman joined CVS Health in 2002 and has held positions of increasing responsibility, most recently serving as senior VP and CFO, pharmacy and consumer wellness.

WOONSOCKET, R.I., Dec. 3, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Len Shankman will be president, Pharmacy and Consumer Wellness (PCW), reporting to Prem Shah, group ...

CVS Health’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported ...

Shankman joined CVS Health in 2002 and has held positions of increasing responsibility, most recently serving as senior vice president and chief financial officer, Pharmacy and Consumer Wellness.